INS and type 2 diabetes mellitus: Indeed, insulin‐stimulated phospho‐PAK was attenuated in obese humans and those with type 2 diabetes, high fat‐fed and ob/ob mice, and during acute infusion of lipids in otherwise lean, healthy adults (Sylow et al.